MesomiR-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MesomiR-1, covering 2017-04-07 to 2017-04-07. Get the full timeline:
Most recent: Clinical Trial Update: MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC [Phase 1]